nodes	percent_of_prediction	percent_of_DWPC	metapath
Irinotecan—Topoisomerase Inhibitors—Etoposide—uterine cancer	0.285	0.43	CiPCiCtD
Irinotecan—Topoisomerase Inhibitors—Epirubicin—uterine cancer	0.196	0.296	CiPCiCtD
Irinotecan—Topoisomerase Inhibitors—Doxorubicin—uterine cancer	0.182	0.274	CiPCiCtD
Irinotecan—SLC22A3—Progesterone—uterine cancer	0.0351	0.149	CbGbCtD
Irinotecan—ABCC1—Progesterone—uterine cancer	0.0229	0.0972	CbGbCtD
Irinotecan—ABCC1—Dactinomycin—uterine cancer	0.0182	0.077	CbGbCtD
Irinotecan—ABCC1—Epirubicin—uterine cancer	0.0131	0.0558	CbGbCtD
Irinotecan—UGT1A1—Etoposide—uterine cancer	0.0125	0.0529	CbGbCtD
Irinotecan—ABCG2—Dactinomycin—uterine cancer	0.0121	0.0516	CbGbCtD
Irinotecan—CYP3A7—Progesterone—uterine cancer	0.0113	0.048	CbGbCtD
Irinotecan—CYP3A7-CYP3A51P—Progesterone—uterine cancer	0.0113	0.048	CbGbCtD
Irinotecan—ABCC1—Etoposide—uterine cancer	0.0102	0.0435	CbGbCtD
Irinotecan—ABCC2—Carboplatin—uterine cancer	0.00903	0.0383	CbGbCtD
Irinotecan—CYP3A5—Progesterone—uterine cancer	0.00849	0.036	CbGbCtD
Irinotecan—ABCG2—Carboplatin—uterine cancer	0.00817	0.0347	CbGbCtD
Irinotecan—ABCC2—Etoposide—uterine cancer	0.00758	0.0322	CbGbCtD
Irinotecan—ABCC1—Doxorubicin—uterine cancer	0.00699	0.0297	CbGbCtD
Irinotecan—ABCG2—Etoposide—uterine cancer	0.00686	0.0291	CbGbCtD
Irinotecan—ABCB1—Progesterone—uterine cancer	0.00552	0.0234	CbGbCtD
Irinotecan—ABCC2—Doxorubicin—uterine cancer	0.00517	0.0219	CbGbCtD
Irinotecan—CYP3A4—Medroxyprogesterone Acetate—uterine cancer	0.005	0.0212	CbGbCtD
Irinotecan—ABCG2—Doxorubicin—uterine cancer	0.00468	0.0198	CbGbCtD
Irinotecan—ABCB1—Dactinomycin—uterine cancer	0.00438	0.0186	CbGbCtD
Irinotecan—CYP3A5—Etoposide—uterine cancer	0.0038	0.0161	CbGbCtD
Irinotecan—CYP3A4—Progesterone—uterine cancer	0.00331	0.014	CbGbCtD
Irinotecan—CYP2B6—Doxorubicin—uterine cancer	0.00329	0.014	CbGbCtD
Irinotecan—ABCB1—Etoposide—uterine cancer	0.00247	0.0105	CbGbCtD
Irinotecan—ABCB1—Doxorubicin—uterine cancer	0.00169	0.00716	CbGbCtD
Irinotecan—CYP3A4—Etoposide—uterine cancer	0.00148	0.00629	CbGbCtD
Irinotecan—CYP3A4—Doxorubicin—uterine cancer	0.00101	0.00429	CbGbCtD
Irinotecan—TOP1MT—female reproductive system—uterine cancer	0.000734	0.0318	CbGeAlD
Irinotecan—TOP1MT—female gonad—uterine cancer	0.000668	0.0289	CbGeAlD
Irinotecan—TOP1—myometrium—uterine cancer	0.000665	0.0288	CbGeAlD
Irinotecan—CES2—myometrium—uterine cancer	0.000603	0.0261	CbGeAlD
Irinotecan—UGT1A9—renal system—uterine cancer	0.000544	0.0236	CbGeAlD
Irinotecan—TOP1—uterine cervix—uterine cancer	0.000517	0.0224	CbGeAlD
Irinotecan—TOP1—smooth muscle tissue—uterine cancer	0.000503	0.0218	CbGeAlD
Irinotecan—TOP1—decidua—uterine cancer	0.000493	0.0213	CbGeAlD
Irinotecan—CES2—uterine cervix—uterine cancer	0.000469	0.0203	CbGeAlD
Irinotecan—TOP1—endometrium—uterine cancer	0.000468	0.0202	CbGeAlD
Irinotecan—CES2—smooth muscle tissue—uterine cancer	0.000456	0.0197	CbGeAlD
Irinotecan—TOP1—mammalian vulva—uterine cancer	0.000452	0.0196	CbGeAlD
Irinotecan—CES2—decidua—uterine cancer	0.000447	0.0193	CbGeAlD
Irinotecan—CES2—renal system—uterine cancer	0.000439	0.019	CbGeAlD
Irinotecan—TOP1—uterus—uterine cancer	0.000431	0.0187	CbGeAlD
Irinotecan—TOP1MT—lymph node—uterine cancer	0.00043	0.0186	CbGeAlD
Irinotecan—CES2—endometrium—uterine cancer	0.000424	0.0184	CbGeAlD
Irinotecan—CES2—mammalian vulva—uterine cancer	0.00041	0.0178	CbGeAlD
Irinotecan—CES2—uterus—uterine cancer	0.000391	0.0169	CbGeAlD
Irinotecan—UGT1A1—renal system—uterine cancer	0.000373	0.0161	CbGeAlD
Irinotecan—TOP1—female gonad—uterine cancer	0.000353	0.0153	CbGeAlD
Irinotecan—CES2—female reproductive system—uterine cancer	0.000351	0.0152	CbGeAlD
Irinotecan—TOP1—vagina—uterine cancer	0.00035	0.0152	CbGeAlD
Irinotecan—SLC22A3—myometrium—uterine cancer	0.000344	0.0149	CbGeAlD
Irinotecan—CES2—female gonad—uterine cancer	0.00032	0.0138	CbGeAlD
Irinotecan—CES2—vagina—uterine cancer	0.000318	0.0138	CbGeAlD
Irinotecan—SLCO1B1—renal system—uterine cancer	0.00031	0.0134	CbGeAlD
Irinotecan—CES1—female reproductive system—uterine cancer	0.000289	0.0125	CbGeAlD
Irinotecan—ABCC1—myometrium—uterine cancer	0.000285	0.0123	CbGeAlD
Irinotecan—SLC22A3—uterine cervix—uterine cancer	0.000268	0.0116	CbGeAlD
Irinotecan—CES1—female gonad—uterine cancer	0.000263	0.0114	CbGeAlD
Irinotecan—SLC22A3—smooth muscle tissue—uterine cancer	0.00026	0.0113	CbGeAlD
Irinotecan—SLC22A3—renal system—uterine cancer	0.000251	0.0109	CbGeAlD
Irinotecan—SLCO1B1—female reproductive system—uterine cancer	0.000249	0.0108	CbGeAlD
Irinotecan—BCHE—myometrium—uterine cancer	0.000244	0.0106	CbGeAlD
Irinotecan—SLC22A3—endometrium—uterine cancer	0.000242	0.0105	CbGeAlD
Irinotecan—ABCG2—myometrium—uterine cancer	0.000236	0.0102	CbGeAlD
Irinotecan—ABCC2—renal system—uterine cancer	0.000235	0.0102	CbGeAlD
Irinotecan—SLC22A3—mammalian vulva—uterine cancer	0.000234	0.0102	CbGeAlD
Irinotecan—TOP1—lymph node—uterine cancer	0.000227	0.00981	CbGeAlD
Irinotecan—ABCC1—uterine cervix—uterine cancer	0.000222	0.00959	CbGeAlD
Irinotecan—ABCC1—decidua—uterine cancer	0.000211	0.00914	CbGeAlD
Irinotecan—CES2—lymph node—uterine cancer	0.000206	0.0089	CbGeAlD
Irinotecan—SLC22A3—female reproductive system—uterine cancer	0.000201	0.00869	CbGeAlD
Irinotecan—ABCC1—endometrium—uterine cancer	0.0002	0.00868	CbGeAlD
Irinotecan—ABCC1—mammalian vulva—uterine cancer	0.000194	0.00839	CbGeAlD
Irinotecan—BCHE—uterine cervix—uterine cancer	0.00019	0.00822	CbGeAlD
Irinotecan—ABCC2—female reproductive system—uterine cancer	0.000188	0.00816	CbGeAlD
Irinotecan—ABCC1—uterus—uterine cancer	0.000185	0.00799	CbGeAlD
Irinotecan—BCHE—smooth muscle tissue—uterine cancer	0.000184	0.00798	CbGeAlD
Irinotecan—ABCG2—uterine cervix—uterine cancer	0.000183	0.00794	CbGeAlD
Irinotecan—SLC22A3—female gonad—uterine cancer	0.000183	0.00791	CbGeAlD
Irinotecan—SLC22A3—vagina—uterine cancer	0.000182	0.00786	CbGeAlD
Irinotecan—ABCG2—decidua—uterine cancer	0.000175	0.00757	CbGeAlD
Irinotecan—BCHE—endometrium—uterine cancer	0.000172	0.00743	CbGeAlD
Irinotecan—CYP3A5—uterine cervix—uterine cancer	0.00017	0.00737	CbGeAlD
Irinotecan—ACHE—lymph node—uterine cancer	0.000169	0.00733	CbGeAlD
Irinotecan—CES1—lymph node—uterine cancer	0.000169	0.00733	CbGeAlD
Irinotecan—BCHE—mammalian vulva—uterine cancer	0.000166	0.00719	CbGeAlD
Irinotecan—ABCG2—endometrium—uterine cancer	0.000166	0.00718	CbGeAlD
Irinotecan—ABCG2—mammalian vulva—uterine cancer	0.000161	0.00695	CbGeAlD
Irinotecan—CYP3A5—renal system—uterine cancer	0.000159	0.0069	CbGeAlD
Irinotecan—CYP2B6—renal system—uterine cancer	0.000158	0.00685	CbGeAlD
Irinotecan—BCHE—uterus—uterine cancer	0.000158	0.00685	CbGeAlD
Irinotecan—ABCG2—uterus—uterine cancer	0.000153	0.00662	CbGeAlD
Irinotecan—ABCC1—female gonad—uterine cancer	0.000151	0.00654	CbGeAlD
Irinotecan—ABCC1—vagina—uterine cancer	0.00015	0.0065	CbGeAlD
Irinotecan—BCHE—female reproductive system—uterine cancer	0.000142	0.00616	CbGeAlD
Irinotecan—BCHE—vagina—uterine cancer	0.000129	0.00557	CbGeAlD
Irinotecan—CYP2B6—female reproductive system—uterine cancer	0.000127	0.00549	CbGeAlD
Irinotecan—ABCG2—female gonad—uterine cancer	0.000125	0.00541	CbGeAlD
Irinotecan—ABCG2—vagina—uterine cancer	0.000124	0.00538	CbGeAlD
Irinotecan—CYP3A4—renal system—uterine cancer	0.00012	0.00518	CbGeAlD
Irinotecan—ALB—lymph node—uterine cancer	0.000118	0.00509	CbGeAlD
Irinotecan—SLC22A3—lymph node—uterine cancer	0.000117	0.00509	CbGeAlD
Irinotecan—ABCB1—myometrium—uterine cancer	0.000116	0.00503	CbGeAlD
Irinotecan—CYP3A5—female gonad—uterine cancer	0.000116	0.00503	CbGeAlD
Irinotecan—CYP3A5—vagina—uterine cancer	0.000115	0.00499	CbGeAlD
Irinotecan—CYP2B6—vagina—uterine cancer	0.000115	0.00496	CbGeAlD
Irinotecan—ABCC2—lymph node—uterine cancer	0.00011	0.00477	CbGeAlD
Irinotecan—ABCC1—lymph node—uterine cancer	9.71e-05	0.0042	CbGeAlD
Irinotecan—CYP3A4—female reproductive system—uterine cancer	9.58e-05	0.00414	CbGeAlD
Irinotecan—ABCB1—epithelium—uterine cancer	9.12e-05	0.00395	CbGeAlD
Irinotecan—ABCB1—uterine cervix—uterine cancer	9.05e-05	0.00392	CbGeAlD
Irinotecan—ABCB1—decidua—uterine cancer	8.62e-05	0.00373	CbGeAlD
Irinotecan—ABCB1—renal system—uterine cancer	8.46e-05	0.00366	CbGeAlD
Irinotecan—BCHE—lymph node—uterine cancer	8.32e-05	0.0036	CbGeAlD
Irinotecan—ABCB1—endometrium—uterine cancer	8.18e-05	0.00354	CbGeAlD
Irinotecan—ABCG2—lymph node—uterine cancer	8.04e-05	0.00348	CbGeAlD
Irinotecan—ABCB1—mammalian vulva—uterine cancer	7.91e-05	0.00343	CbGeAlD
Irinotecan—ABCB1—uterus—uterine cancer	7.54e-05	0.00326	CbGeAlD
Irinotecan—Anorexia—Dactinomycin—uterine cancer	6.96e-05	0.00114	CcSEcCtD
Irinotecan—Neoplasm—Doxorubicin—uterine cancer	6.94e-05	0.00114	CcSEcCtD
Irinotecan—Blood alkaline phosphatase increased—Epirubicin—uterine cancer	6.93e-05	0.00113	CcSEcCtD
Irinotecan—Cardiac disorder—Etoposide—uterine cancer	6.9e-05	0.00113	CcSEcCtD
Irinotecan—Flushing—Etoposide—uterine cancer	6.9e-05	0.00113	CcSEcCtD
Irinotecan—Hypersensitivity—Medroxyprogesterone Acetate—uterine cancer	6.89e-05	0.00113	CcSEcCtD
Irinotecan—Dizziness—Progesterone—uterine cancer	6.83e-05	0.00112	CcSEcCtD
Irinotecan—ABCB1—female reproductive system—uterine cancer	6.78e-05	0.00293	CbGeAlD
Irinotecan—Angiopathy—Etoposide—uterine cancer	6.75e-05	0.0011	CcSEcCtD
Irinotecan—Immune system disorder—Etoposide—uterine cancer	6.72e-05	0.0011	CcSEcCtD
Irinotecan—Asthenia—Medroxyprogesterone Acetate—uterine cancer	6.71e-05	0.0011	CcSEcCtD
Irinotecan—Mediastinal disorder—Etoposide—uterine cancer	6.7e-05	0.0011	CcSEcCtD
Irinotecan—Chills—Etoposide—uterine cancer	6.67e-05	0.00109	CcSEcCtD
Irinotecan—Sepsis—Doxorubicin—uterine cancer	6.66e-05	0.00109	CcSEcCtD
Irinotecan—Alopecia—Etoposide—uterine cancer	6.57e-05	0.00107	CcSEcCtD
Irinotecan—Vomiting—Progesterone—uterine cancer	6.57e-05	0.00107	CcSEcCtD
Irinotecan—Renal failure acute—Epirubicin—uterine cancer	6.53e-05	0.00107	CcSEcCtD
Irinotecan—Rash—Progesterone—uterine cancer	6.51e-05	0.00106	CcSEcCtD
Irinotecan—Dermatitis—Progesterone—uterine cancer	6.51e-05	0.00106	CcSEcCtD
Irinotecan—Headache—Progesterone—uterine cancer	6.47e-05	0.00106	CcSEcCtD
Irinotecan—Thrombophlebitis—Doxorubicin—uterine cancer	6.44e-05	0.00105	CcSEcCtD
Irinotecan—Blood alkaline phosphatase increased—Doxorubicin—uterine cancer	6.41e-05	0.00105	CcSEcCtD
Irinotecan—Diarrhoea—Medroxyprogesterone Acetate—uterine cancer	6.4e-05	0.00105	CcSEcCtD
Irinotecan—Dermatitis exfoliative—Epirubicin—uterine cancer	6.39e-05	0.00104	CcSEcCtD
Irinotecan—Decreased appetite—Dactinomycin—uterine cancer	6.35e-05	0.00104	CcSEcCtD
Irinotecan—Renal impairment—Epirubicin—uterine cancer	6.33e-05	0.00104	CcSEcCtD
Irinotecan—Fatigue—Dactinomycin—uterine cancer	6.29e-05	0.00103	CcSEcCtD
Irinotecan—Back pain—Etoposide—uterine cancer	6.26e-05	0.00102	CcSEcCtD
Irinotecan—Pain—Dactinomycin—uterine cancer	6.24e-05	0.00102	CcSEcCtD
Irinotecan—Anaphylactoid reaction—Epirubicin—uterine cancer	6.23e-05	0.00102	CcSEcCtD
Irinotecan—Muscle spasms—Etoposide—uterine cancer	6.22e-05	0.00102	CcSEcCtD
Irinotecan—Dizziness—Medroxyprogesterone Acetate—uterine cancer	6.19e-05	0.00101	CcSEcCtD
Irinotecan—ABCB1—female gonad—uterine cancer	6.17e-05	0.00267	CbGeAlD
Irinotecan—Cerebrovascular accident—Epirubicin—uterine cancer	6.15e-05	0.00101	CcSEcCtD
Irinotecan—Nausea—Progesterone—uterine cancer	6.13e-05	0.001	CcSEcCtD
Irinotecan—ABCB1—vagina—uterine cancer	6.13e-05	0.00265	CbGeAlD
Irinotecan—Hyponatraemia—Epirubicin—uterine cancer	6.05e-05	0.000989	CcSEcCtD
Irinotecan—Renal failure acute—Doxorubicin—uterine cancer	6.04e-05	0.000988	CcSEcCtD
Irinotecan—Osteoarthritis—Epirubicin—uterine cancer	6.03e-05	0.000985	CcSEcCtD
Irinotecan—Gastrointestinal haemorrhage—Epirubicin—uterine cancer	6.03e-05	0.000985	CcSEcCtD
Irinotecan—Feeling abnormal—Dactinomycin—uterine cancer	6.02e-05	0.000984	CcSEcCtD
Irinotecan—Ill-defined disorder—Etoposide—uterine cancer	6.01e-05	0.000982	CcSEcCtD
Irinotecan—Anaemia—Etoposide—uterine cancer	5.98e-05	0.000979	CcSEcCtD
Irinotecan—Gastrointestinal pain—Dactinomycin—uterine cancer	5.97e-05	0.000976	CcSEcCtD
Irinotecan—Vomiting—Medroxyprogesterone Acetate—uterine cancer	5.95e-05	0.000973	CcSEcCtD
Irinotecan—Dermatitis exfoliative—Doxorubicin—uterine cancer	5.91e-05	0.000966	CcSEcCtD
Irinotecan—Rash—Medroxyprogesterone Acetate—uterine cancer	5.9e-05	0.000965	CcSEcCtD
Irinotecan—Dermatitis—Medroxyprogesterone Acetate—uterine cancer	5.9e-05	0.000964	CcSEcCtD
Irinotecan—Headache—Medroxyprogesterone Acetate—uterine cancer	5.86e-05	0.000959	CcSEcCtD
Irinotecan—Renal impairment—Doxorubicin—uterine cancer	5.86e-05	0.000958	CcSEcCtD
Irinotecan—Malaise—Etoposide—uterine cancer	5.84e-05	0.000955	CcSEcCtD
Irinotecan—Vertigo—Etoposide—uterine cancer	5.82e-05	0.000951	CcSEcCtD
Irinotecan—Leukopenia—Etoposide—uterine cancer	5.79e-05	0.000948	CcSEcCtD
Irinotecan—Abdominal pain—Dactinomycin—uterine cancer	5.77e-05	0.000944	CcSEcCtD
Irinotecan—Body temperature increased—Dactinomycin—uterine cancer	5.77e-05	0.000944	CcSEcCtD
Irinotecan—Anaphylactoid reaction—Doxorubicin—uterine cancer	5.76e-05	0.000942	CcSEcCtD
Irinotecan—Cardiac arrest—Epirubicin—uterine cancer	5.73e-05	0.000937	CcSEcCtD
Irinotecan—Loss of consciousness—Etoposide—uterine cancer	5.69e-05	0.00093	CcSEcCtD
Irinotecan—Cerebrovascular accident—Doxorubicin—uterine cancer	5.69e-05	0.00093	CcSEcCtD
Irinotecan—Cough—Etoposide—uterine cancer	5.65e-05	0.000924	CcSEcCtD
Irinotecan—Blood creatinine increased—Epirubicin—uterine cancer	5.64e-05	0.000923	CcSEcCtD
Irinotecan—Dehydration—Epirubicin—uterine cancer	5.6e-05	0.000916	CcSEcCtD
Irinotecan—Hyponatraemia—Doxorubicin—uterine cancer	5.6e-05	0.000915	CcSEcCtD
Irinotecan—Hypertension—Etoposide—uterine cancer	5.59e-05	0.000914	CcSEcCtD
Irinotecan—Osteoarthritis—Doxorubicin—uterine cancer	5.58e-05	0.000912	CcSEcCtD
Irinotecan—Gastrointestinal haemorrhage—Doxorubicin—uterine cancer	5.58e-05	0.000912	CcSEcCtD
Irinotecan—Nausea—Medroxyprogesterone Acetate—uterine cancer	5.56e-05	0.000909	CcSEcCtD
Irinotecan—Orthostatic hypotension—Epirubicin—uterine cancer	5.5e-05	0.0009	CcSEcCtD
Irinotecan—Hypokalaemia—Epirubicin—uterine cancer	5.48e-05	0.000897	CcSEcCtD
Irinotecan—Discomfort—Etoposide—uterine cancer	5.45e-05	0.000891	CcSEcCtD
Irinotecan—Aspartate aminotransferase increased—Epirubicin—uterine cancer	5.43e-05	0.000887	CcSEcCtD
Irinotecan—Hypersensitivity—Dactinomycin—uterine cancer	5.38e-05	0.00088	CcSEcCtD
Irinotecan—Confusional state—Etoposide—uterine cancer	5.33e-05	0.000871	CcSEcCtD
Irinotecan—Cardiac arrest—Doxorubicin—uterine cancer	5.3e-05	0.000867	CcSEcCtD
Irinotecan—Anaphylactic shock—Etoposide—uterine cancer	5.28e-05	0.000864	CcSEcCtD
Irinotecan—Infection—Etoposide—uterine cancer	5.25e-05	0.000858	CcSEcCtD
Irinotecan—Abdominal distension—Epirubicin—uterine cancer	5.24e-05	0.000857	CcSEcCtD
Irinotecan—Asthenia—Dactinomycin—uterine cancer	5.24e-05	0.000857	CcSEcCtD
Irinotecan—Blood creatinine increased—Doxorubicin—uterine cancer	5.22e-05	0.000854	CcSEcCtD
Irinotecan—Dehydration—Doxorubicin—uterine cancer	5.18e-05	0.000848	CcSEcCtD
Irinotecan—Thrombocytopenia—Etoposide—uterine cancer	5.17e-05	0.000846	CcSEcCtD
Irinotecan—Hyperhidrosis—Etoposide—uterine cancer	5.11e-05	0.000835	CcSEcCtD
Irinotecan—Pancreatitis—Epirubicin—uterine cancer	5.11e-05	0.000835	CcSEcCtD
Irinotecan—Orthostatic hypotension—Doxorubicin—uterine cancer	5.09e-05	0.000833	CcSEcCtD
Irinotecan—Hypokalaemia—Doxorubicin—uterine cancer	5.07e-05	0.00083	CcSEcCtD
Irinotecan—Angina pectoris—Epirubicin—uterine cancer	5.07e-05	0.00083	CcSEcCtD
Irinotecan—Anorexia—Etoposide—uterine cancer	5.04e-05	0.000824	CcSEcCtD
Irinotecan—Aspartate aminotransferase increased—Doxorubicin—uterine cancer	5.02e-05	0.000821	CcSEcCtD
Irinotecan—Diarrhoea—Dactinomycin—uterine cancer	4.99e-05	0.000817	CcSEcCtD
Irinotecan—Hypotension—Etoposide—uterine cancer	4.94e-05	0.000807	CcSEcCtD
Irinotecan—Neutropenia—Epirubicin—uterine cancer	4.87e-05	0.000796	CcSEcCtD
Irinotecan—Abdominal distension—Doxorubicin—uterine cancer	4.85e-05	0.000793	CcSEcCtD
Irinotecan—Upper respiratory tract infection—Epirubicin—uterine cancer	4.84e-05	0.000792	CcSEcCtD
Irinotecan—Paraesthesia—Etoposide—uterine cancer	4.74e-05	0.000776	CcSEcCtD
Irinotecan—Pancreatitis—Doxorubicin—uterine cancer	4.72e-05	0.000773	CcSEcCtD
Irinotecan—Weight decreased—Epirubicin—uterine cancer	4.71e-05	0.000771	CcSEcCtD
Irinotecan—Dyspnoea—Etoposide—uterine cancer	4.71e-05	0.00077	CcSEcCtD
Irinotecan—Somnolence—Etoposide—uterine cancer	4.7e-05	0.000768	CcSEcCtD
Irinotecan—Angina pectoris—Doxorubicin—uterine cancer	4.69e-05	0.000768	CcSEcCtD
Irinotecan—Pneumonia—Epirubicin—uterine cancer	4.67e-05	0.000764	CcSEcCtD
Irinotecan—Vomiting—Dactinomycin—uterine cancer	4.64e-05	0.000759	CcSEcCtD
Irinotecan—Rash—Dactinomycin—uterine cancer	4.6e-05	0.000753	CcSEcCtD
Irinotecan—Decreased appetite—Etoposide—uterine cancer	4.59e-05	0.000751	CcSEcCtD
Irinotecan—Renal failure—Epirubicin—uterine cancer	4.56e-05	0.000746	CcSEcCtD
Irinotecan—Gastrointestinal disorder—Etoposide—uterine cancer	4.56e-05	0.000746	CcSEcCtD
Irinotecan—Fatigue—Etoposide—uterine cancer	4.55e-05	0.000745	CcSEcCtD
Irinotecan—Stomatitis—Epirubicin—uterine cancer	4.53e-05	0.00074	CcSEcCtD
Irinotecan—Jaundice—Epirubicin—uterine cancer	4.53e-05	0.00074	CcSEcCtD
Irinotecan—Pain—Etoposide—uterine cancer	4.52e-05	0.000739	CcSEcCtD
Irinotecan—Constipation—Etoposide—uterine cancer	4.52e-05	0.000739	CcSEcCtD
Irinotecan—Neutropenia—Doxorubicin—uterine cancer	4.51e-05	0.000737	CcSEcCtD
Irinotecan—Upper respiratory tract infection—Doxorubicin—uterine cancer	4.48e-05	0.000732	CcSEcCtD
Irinotecan—Sweating—Epirubicin—uterine cancer	4.45e-05	0.000728	CcSEcCtD
Irinotecan—Weight decreased—Doxorubicin—uterine cancer	4.36e-05	0.000713	CcSEcCtD
Irinotecan—Feeling abnormal—Etoposide—uterine cancer	4.35e-05	0.000712	CcSEcCtD
Irinotecan—Nausea—Dactinomycin—uterine cancer	4.34e-05	0.000709	CcSEcCtD
Irinotecan—Pneumonia—Doxorubicin—uterine cancer	4.32e-05	0.000707	CcSEcCtD
Irinotecan—Gastrointestinal pain—Etoposide—uterine cancer	4.32e-05	0.000707	CcSEcCtD
Irinotecan—Bradycardia—Epirubicin—uterine cancer	4.24e-05	0.000694	CcSEcCtD
Irinotecan—Renal failure—Doxorubicin—uterine cancer	4.22e-05	0.000691	CcSEcCtD
Irinotecan—Haemoglobin—Epirubicin—uterine cancer	4.19e-05	0.000685	CcSEcCtD
Irinotecan—Stomatitis—Doxorubicin—uterine cancer	4.19e-05	0.000685	CcSEcCtD
Irinotecan—Jaundice—Doxorubicin—uterine cancer	4.19e-05	0.000685	CcSEcCtD
Irinotecan—Rhinitis—Epirubicin—uterine cancer	4.18e-05	0.000683	CcSEcCtD
Irinotecan—Abdominal pain—Etoposide—uterine cancer	4.18e-05	0.000683	CcSEcCtD
Irinotecan—Body temperature increased—Etoposide—uterine cancer	4.18e-05	0.000683	CcSEcCtD
Irinotecan—Haemorrhage—Epirubicin—uterine cancer	4.17e-05	0.000682	CcSEcCtD
Irinotecan—Sweating—Doxorubicin—uterine cancer	4.12e-05	0.000674	CcSEcCtD
Irinotecan—Connective tissue disorder—Epirubicin—uterine cancer	4.1e-05	0.00067	CcSEcCtD
Irinotecan—Visual impairment—Epirubicin—uterine cancer	4.02e-05	0.000657	CcSEcCtD
Irinotecan—ABCB1—lymph node—uterine cancer	3.96e-05	0.00172	CbGeAlD
Irinotecan—Bradycardia—Doxorubicin—uterine cancer	3.93e-05	0.000642	CcSEcCtD
Irinotecan—Hypersensitivity—Etoposide—uterine cancer	3.89e-05	0.000637	CcSEcCtD
Irinotecan—Haemoglobin—Doxorubicin—uterine cancer	3.88e-05	0.000634	CcSEcCtD
Irinotecan—Cardiac disorder—Epirubicin—uterine cancer	3.87e-05	0.000633	CcSEcCtD
Irinotecan—Flushing—Epirubicin—uterine cancer	3.87e-05	0.000633	CcSEcCtD
Irinotecan—Rhinitis—Doxorubicin—uterine cancer	3.87e-05	0.000632	CcSEcCtD
Irinotecan—Haemorrhage—Doxorubicin—uterine cancer	3.86e-05	0.000631	CcSEcCtD
Irinotecan—Asthenia—Etoposide—uterine cancer	3.79e-05	0.00062	CcSEcCtD
Irinotecan—Connective tissue disorder—Doxorubicin—uterine cancer	3.79e-05	0.00062	CcSEcCtD
Irinotecan—Angiopathy—Epirubicin—uterine cancer	3.78e-05	0.000619	CcSEcCtD
Irinotecan—Immune system disorder—Epirubicin—uterine cancer	3.77e-05	0.000616	CcSEcCtD
Irinotecan—Mediastinal disorder—Epirubicin—uterine cancer	3.76e-05	0.000614	CcSEcCtD
Irinotecan—Chills—Epirubicin—uterine cancer	3.74e-05	0.000612	CcSEcCtD
Irinotecan—Arrhythmia—Epirubicin—uterine cancer	3.72e-05	0.000609	CcSEcCtD
Irinotecan—Visual impairment—Doxorubicin—uterine cancer	3.72e-05	0.000608	CcSEcCtD
Irinotecan—Alopecia—Epirubicin—uterine cancer	3.68e-05	0.000602	CcSEcCtD
Irinotecan—Diarrhoea—Etoposide—uterine cancer	3.61e-05	0.000591	CcSEcCtD
Irinotecan—Flushing—Doxorubicin—uterine cancer	3.58e-05	0.000585	CcSEcCtD
Irinotecan—Cardiac disorder—Doxorubicin—uterine cancer	3.58e-05	0.000585	CcSEcCtD
Irinotecan—Flatulence—Epirubicin—uterine cancer	3.58e-05	0.000585	CcSEcCtD
Irinotecan—Back pain—Epirubicin—uterine cancer	3.51e-05	0.000574	CcSEcCtD
Irinotecan—Angiopathy—Doxorubicin—uterine cancer	3.5e-05	0.000572	CcSEcCtD
Irinotecan—Dizziness—Etoposide—uterine cancer	3.49e-05	0.000571	CcSEcCtD
Irinotecan—Muscle spasms—Epirubicin—uterine cancer	3.49e-05	0.000571	CcSEcCtD
Irinotecan—Immune system disorder—Doxorubicin—uterine cancer	3.48e-05	0.00057	CcSEcCtD
Irinotecan—Mediastinal disorder—Doxorubicin—uterine cancer	3.48e-05	0.000568	CcSEcCtD
Irinotecan—Chills—Doxorubicin—uterine cancer	3.46e-05	0.000566	CcSEcCtD
Irinotecan—Arrhythmia—Doxorubicin—uterine cancer	3.45e-05	0.000563	CcSEcCtD
Irinotecan—Alopecia—Doxorubicin—uterine cancer	3.41e-05	0.000557	CcSEcCtD
Irinotecan—Ill-defined disorder—Epirubicin—uterine cancer	3.37e-05	0.000551	CcSEcCtD
Irinotecan—Vomiting—Etoposide—uterine cancer	3.36e-05	0.000549	CcSEcCtD
Irinotecan—Anaemia—Epirubicin—uterine cancer	3.35e-05	0.000549	CcSEcCtD
Irinotecan—Rash—Etoposide—uterine cancer	3.33e-05	0.000545	CcSEcCtD
Irinotecan—Dermatitis—Etoposide—uterine cancer	3.33e-05	0.000544	CcSEcCtD
Irinotecan—Headache—Etoposide—uterine cancer	3.31e-05	0.000541	CcSEcCtD
Irinotecan—Flatulence—Doxorubicin—uterine cancer	3.31e-05	0.000541	CcSEcCtD
Irinotecan—Malaise—Epirubicin—uterine cancer	3.27e-05	0.000535	CcSEcCtD
Irinotecan—Vertigo—Epirubicin—uterine cancer	3.26e-05	0.000533	CcSEcCtD
Irinotecan—Syncope—Epirubicin—uterine cancer	3.25e-05	0.000532	CcSEcCtD
Irinotecan—Leukopenia—Epirubicin—uterine cancer	3.25e-05	0.000531	CcSEcCtD
Irinotecan—Back pain—Doxorubicin—uterine cancer	3.25e-05	0.000531	CcSEcCtD
Irinotecan—Muscle spasms—Doxorubicin—uterine cancer	3.23e-05	0.000528	CcSEcCtD
Irinotecan—Loss of consciousness—Epirubicin—uterine cancer	3.19e-05	0.000522	CcSEcCtD
Irinotecan—Cough—Epirubicin—uterine cancer	3.17e-05	0.000518	CcSEcCtD
Irinotecan—Nausea—Etoposide—uterine cancer	3.14e-05	0.000513	CcSEcCtD
Irinotecan—Hypertension—Epirubicin—uterine cancer	3.13e-05	0.000512	CcSEcCtD
Irinotecan—Ill-defined disorder—Doxorubicin—uterine cancer	3.12e-05	0.000509	CcSEcCtD
Irinotecan—Anaemia—Doxorubicin—uterine cancer	3.1e-05	0.000508	CcSEcCtD
Irinotecan—Discomfort—Epirubicin—uterine cancer	3.05e-05	0.000499	CcSEcCtD
Irinotecan—Malaise—Doxorubicin—uterine cancer	3.03e-05	0.000495	CcSEcCtD
Irinotecan—Vertigo—Doxorubicin—uterine cancer	3.02e-05	0.000493	CcSEcCtD
Irinotecan—Syncope—Doxorubicin—uterine cancer	3.01e-05	0.000492	CcSEcCtD
Irinotecan—Leukopenia—Doxorubicin—uterine cancer	3.01e-05	0.000492	CcSEcCtD
Irinotecan—Confusional state—Epirubicin—uterine cancer	2.99e-05	0.000488	CcSEcCtD
Irinotecan—Anaphylactic shock—Epirubicin—uterine cancer	2.96e-05	0.000484	CcSEcCtD
Irinotecan—Oedema—Epirubicin—uterine cancer	2.96e-05	0.000484	CcSEcCtD
Irinotecan—Loss of consciousness—Doxorubicin—uterine cancer	2.95e-05	0.000483	CcSEcCtD
Irinotecan—Infection—Epirubicin—uterine cancer	2.94e-05	0.000481	CcSEcCtD
Irinotecan—Cough—Doxorubicin—uterine cancer	2.93e-05	0.000479	CcSEcCtD
Irinotecan—Shock—Epirubicin—uterine cancer	2.91e-05	0.000477	CcSEcCtD
Irinotecan—Nervous system disorder—Epirubicin—uterine cancer	2.9e-05	0.000475	CcSEcCtD
Irinotecan—Thrombocytopenia—Epirubicin—uterine cancer	2.9e-05	0.000474	CcSEcCtD
Irinotecan—Hypertension—Doxorubicin—uterine cancer	2.9e-05	0.000474	CcSEcCtD
Irinotecan—Hyperhidrosis—Epirubicin—uterine cancer	2.86e-05	0.000468	CcSEcCtD
Irinotecan—Discomfort—Doxorubicin—uterine cancer	2.82e-05	0.000462	CcSEcCtD
Irinotecan—Anorexia—Epirubicin—uterine cancer	2.82e-05	0.000462	CcSEcCtD
Irinotecan—Hypotension—Epirubicin—uterine cancer	2.77e-05	0.000453	CcSEcCtD
Irinotecan—Confusional state—Doxorubicin—uterine cancer	2.76e-05	0.000452	CcSEcCtD
Irinotecan—Oedema—Doxorubicin—uterine cancer	2.74e-05	0.000448	CcSEcCtD
Irinotecan—Anaphylactic shock—Doxorubicin—uterine cancer	2.74e-05	0.000448	CcSEcCtD
Irinotecan—Infection—Doxorubicin—uterine cancer	2.72e-05	0.000445	CcSEcCtD
Irinotecan—Shock—Doxorubicin—uterine cancer	2.7e-05	0.000441	CcSEcCtD
Irinotecan—Nervous system disorder—Doxorubicin—uterine cancer	2.69e-05	0.000439	CcSEcCtD
Irinotecan—Thrombocytopenia—Doxorubicin—uterine cancer	2.68e-05	0.000439	CcSEcCtD
Irinotecan—Insomnia—Epirubicin—uterine cancer	2.68e-05	0.000438	CcSEcCtD
Irinotecan—Paraesthesia—Epirubicin—uterine cancer	2.66e-05	0.000435	CcSEcCtD
Irinotecan—Hyperhidrosis—Doxorubicin—uterine cancer	2.65e-05	0.000433	CcSEcCtD
Irinotecan—Dyspnoea—Epirubicin—uterine cancer	2.64e-05	0.000432	CcSEcCtD
Irinotecan—Somnolence—Epirubicin—uterine cancer	2.63e-05	0.000431	CcSEcCtD
Irinotecan—Anorexia—Doxorubicin—uterine cancer	2.61e-05	0.000427	CcSEcCtD
Irinotecan—Dyspepsia—Epirubicin—uterine cancer	2.61e-05	0.000426	CcSEcCtD
Irinotecan—Decreased appetite—Epirubicin—uterine cancer	2.57e-05	0.000421	CcSEcCtD
Irinotecan—Hypotension—Doxorubicin—uterine cancer	2.56e-05	0.000419	CcSEcCtD
Irinotecan—Gastrointestinal disorder—Epirubicin—uterine cancer	2.56e-05	0.000418	CcSEcCtD
Irinotecan—Fatigue—Epirubicin—uterine cancer	2.55e-05	0.000418	CcSEcCtD
Irinotecan—Pain—Epirubicin—uterine cancer	2.53e-05	0.000414	CcSEcCtD
Irinotecan—Constipation—Epirubicin—uterine cancer	2.53e-05	0.000414	CcSEcCtD
Irinotecan—Insomnia—Doxorubicin—uterine cancer	2.48e-05	0.000405	CcSEcCtD
Irinotecan—Paraesthesia—Doxorubicin—uterine cancer	2.46e-05	0.000402	CcSEcCtD
Irinotecan—Dyspnoea—Doxorubicin—uterine cancer	2.44e-05	0.0004	CcSEcCtD
Irinotecan—Feeling abnormal—Epirubicin—uterine cancer	2.44e-05	0.000399	CcSEcCtD
Irinotecan—Somnolence—Doxorubicin—uterine cancer	2.44e-05	0.000398	CcSEcCtD
Irinotecan—Gastrointestinal pain—Epirubicin—uterine cancer	2.42e-05	0.000396	CcSEcCtD
Irinotecan—Dyspepsia—Doxorubicin—uterine cancer	2.41e-05	0.000394	CcSEcCtD
Irinotecan—Decreased appetite—Doxorubicin—uterine cancer	2.38e-05	0.00039	CcSEcCtD
Irinotecan—Gastrointestinal disorder—Doxorubicin—uterine cancer	2.37e-05	0.000387	CcSEcCtD
Irinotecan—Fatigue—Doxorubicin—uterine cancer	2.36e-05	0.000386	CcSEcCtD
Irinotecan—Pain—Doxorubicin—uterine cancer	2.34e-05	0.000383	CcSEcCtD
Irinotecan—Constipation—Doxorubicin—uterine cancer	2.34e-05	0.000383	CcSEcCtD
Irinotecan—Abdominal pain—Epirubicin—uterine cancer	2.34e-05	0.000383	CcSEcCtD
Irinotecan—Body temperature increased—Epirubicin—uterine cancer	2.34e-05	0.000383	CcSEcCtD
Irinotecan—Feeling abnormal—Doxorubicin—uterine cancer	2.26e-05	0.000369	CcSEcCtD
Irinotecan—Gastrointestinal pain—Doxorubicin—uterine cancer	2.24e-05	0.000366	CcSEcCtD
Irinotecan—Hypersensitivity—Epirubicin—uterine cancer	2.18e-05	0.000357	CcSEcCtD
Irinotecan—Abdominal pain—Doxorubicin—uterine cancer	2.17e-05	0.000354	CcSEcCtD
Irinotecan—Body temperature increased—Doxorubicin—uterine cancer	2.17e-05	0.000354	CcSEcCtD
Irinotecan—Asthenia—Epirubicin—uterine cancer	2.12e-05	0.000347	CcSEcCtD
Irinotecan—Diarrhoea—Epirubicin—uterine cancer	2.03e-05	0.000331	CcSEcCtD
Irinotecan—Hypersensitivity—Doxorubicin—uterine cancer	2.02e-05	0.00033	CcSEcCtD
Irinotecan—Asthenia—Doxorubicin—uterine cancer	1.97e-05	0.000322	CcSEcCtD
Irinotecan—Dizziness—Epirubicin—uterine cancer	1.96e-05	0.00032	CcSEcCtD
Irinotecan—Vomiting—Epirubicin—uterine cancer	1.88e-05	0.000308	CcSEcCtD
Irinotecan—Diarrhoea—Doxorubicin—uterine cancer	1.87e-05	0.000307	CcSEcCtD
Irinotecan—Rash—Epirubicin—uterine cancer	1.87e-05	0.000305	CcSEcCtD
Irinotecan—Dermatitis—Epirubicin—uterine cancer	1.87e-05	0.000305	CcSEcCtD
Irinotecan—Headache—Epirubicin—uterine cancer	1.86e-05	0.000303	CcSEcCtD
Irinotecan—Dizziness—Doxorubicin—uterine cancer	1.81e-05	0.000296	CcSEcCtD
Irinotecan—Nausea—Epirubicin—uterine cancer	1.76e-05	0.000288	CcSEcCtD
Irinotecan—Vomiting—Doxorubicin—uterine cancer	1.74e-05	0.000285	CcSEcCtD
Irinotecan—Rash—Doxorubicin—uterine cancer	1.73e-05	0.000283	CcSEcCtD
Irinotecan—Dermatitis—Doxorubicin—uterine cancer	1.73e-05	0.000282	CcSEcCtD
Irinotecan—Headache—Doxorubicin—uterine cancer	1.72e-05	0.000281	CcSEcCtD
Irinotecan—Nausea—Doxorubicin—uterine cancer	1.63e-05	0.000266	CcSEcCtD
Irinotecan—BCHE—Metabolism—AKR1C1—uterine cancer	8.28e-06	0.000497	CbGpPWpGaD
Irinotecan—ACHE—Metabolism—RRM2—uterine cancer	8.27e-06	0.000497	CbGpPWpGaD
Irinotecan—SLCO1B1—Metabolism—AKR1C1—uterine cancer	8.07e-06	0.000485	CbGpPWpGaD
Irinotecan—ACHE—Metabolism—DCN—uterine cancer	8.03e-06	0.000482	CbGpPWpGaD
Irinotecan—ABCG2—Metabolism—POLD1—uterine cancer	7.99e-06	0.00048	CbGpPWpGaD
Irinotecan—ALB—Metabolism of lipids and lipoproteins—AKR1C3—uterine cancer	7.97e-06	0.000479	CbGpPWpGaD
Irinotecan—CYP3A7—Metabolism—POLD1—uterine cancer	7.92e-06	0.000475	CbGpPWpGaD
Irinotecan—ACHE—Transmission across Chemical Synapses—HRAS—uterine cancer	7.87e-06	0.000473	CbGpPWpGaD
Irinotecan—UGT1A1—Metabolism—RRM2—uterine cancer	7.85e-06	0.000471	CbGpPWpGaD
Irinotecan—UGT1A9—Metabolism—RRM2—uterine cancer	7.85e-06	0.000471	CbGpPWpGaD
Irinotecan—ABCC1—Disease—AKR1C3—uterine cancer	7.81e-06	0.000469	CbGpPWpGaD
Irinotecan—UGT1A1—Metabolism—DCN—uterine cancer	7.62e-06	0.000457	CbGpPWpGaD
Irinotecan—UGT1A9—Metabolism—DCN—uterine cancer	7.62e-06	0.000457	CbGpPWpGaD
Irinotecan—ABCB1—Metabolism—NDUFB11—uterine cancer	7.61e-06	0.000457	CbGpPWpGaD
Irinotecan—ABCB1—Metabolism—SRD5A2—uterine cancer	7.61e-06	0.000457	CbGpPWpGaD
Irinotecan—ABCC1—Disease—HMGA1—uterine cancer	7.61e-06	0.000457	CbGpPWpGaD
Irinotecan—ABCC1—Metabolism—RRM2—uterine cancer	7.57e-06	0.000454	CbGpPWpGaD
Irinotecan—ACHE—Metabolism—CYP11A1—uterine cancer	7.57e-06	0.000454	CbGpPWpGaD
Irinotecan—ABCG2—Metabolism—AKR1C1—uterine cancer	7.47e-06	0.000449	CbGpPWpGaD
Irinotecan—CYP2B6—Metabolism—AKR1B1—uterine cancer	7.46e-06	0.000448	CbGpPWpGaD
Irinotecan—CYP2B6—Metabolism—STAR—uterine cancer	7.46e-06	0.000448	CbGpPWpGaD
Irinotecan—CYP3A7—Metabolism—AKR1C1—uterine cancer	7.41e-06	0.000445	CbGpPWpGaD
Irinotecan—BCHE—Metabolism—RRM2—uterine cancer	7.38e-06	0.000443	CbGpPWpGaD
Irinotecan—ABCC1—Metabolism—DCN—uterine cancer	7.35e-06	0.000441	CbGpPWpGaD
Irinotecan—ABCB1—HIF-1-alpha transcription factor network—AKT1—uterine cancer	7.35e-06	0.000441	CbGpPWpGaD
Irinotecan—CYP3A5—Metabolism—STAR—uterine cancer	7.3e-06	0.000438	CbGpPWpGaD
Irinotecan—CYP3A5—Metabolism—AKR1B1—uterine cancer	7.3e-06	0.000438	CbGpPWpGaD
Irinotecan—ACHE—Integrated Pancreatic Cancer Pathway—AKT1—uterine cancer	7.21e-06	0.000433	CbGpPWpGaD
Irinotecan—SLCO1B1—Metabolism—RRM2—uterine cancer	7.19e-06	0.000432	CbGpPWpGaD
Irinotecan—UGT1A1—Metabolism—CYP11A1—uterine cancer	7.18e-06	0.000431	CbGpPWpGaD
Irinotecan—UGT1A9—Metabolism—CYP11A1—uterine cancer	7.18e-06	0.000431	CbGpPWpGaD
Irinotecan—BCHE—Metabolism—DCN—uterine cancer	7.17e-06	0.00043	CbGpPWpGaD
Irinotecan—ACHE—Metabolism—AKR1C3—uterine cancer	7.15e-06	0.000429	CbGpPWpGaD
Irinotecan—SLC22A3—Metabolism—STK11—uterine cancer	7.07e-06	0.000425	CbGpPWpGaD
Irinotecan—SLC22A3—Metabolism—CYP19A1—uterine cancer	7.07e-06	0.000425	CbGpPWpGaD
Irinotecan—BCHE—Transmission across Chemical Synapses—HRAS—uterine cancer	7.02e-06	0.000422	CbGpPWpGaD
Irinotecan—SLCO1B1—Metabolism—DCN—uterine cancer	6.98e-06	0.000419	CbGpPWpGaD
Irinotecan—ABCC1—Disease—FBXW7—uterine cancer	6.96e-06	0.000418	CbGpPWpGaD
Irinotecan—ABCC1—Metabolism—CYP11A1—uterine cancer	6.92e-06	0.000416	CbGpPWpGaD
Irinotecan—UGT1A1—Metabolism—AKR1C3—uterine cancer	6.78e-06	0.000407	CbGpPWpGaD
Irinotecan—UGT1A9—Metabolism—AKR1C3—uterine cancer	6.78e-06	0.000407	CbGpPWpGaD
Irinotecan—BCHE—Metabolism—CYP11A1—uterine cancer	6.75e-06	0.000405	CbGpPWpGaD
Irinotecan—ABCG2—Metabolism—RRM2—uterine cancer	6.66e-06	0.0004	CbGpPWpGaD
Irinotecan—CYP3A7—Metabolism—RRM2—uterine cancer	6.6e-06	0.000396	CbGpPWpGaD
Irinotecan—SLCO1B1—Metabolism—CYP11A1—uterine cancer	6.58e-06	0.000395	CbGpPWpGaD
Irinotecan—ABCC1—Metabolism—AKR1C3—uterine cancer	6.54e-06	0.000392	CbGpPWpGaD
Irinotecan—ABCG2—Metabolism—DCN—uterine cancer	6.47e-06	0.000388	CbGpPWpGaD
Irinotecan—CYP3A7—Metabolism—DCN—uterine cancer	6.41e-06	0.000385	CbGpPWpGaD
Irinotecan—ABCB1—Integrated Pancreatic Cancer Pathway—ERBB2—uterine cancer	6.39e-06	0.000383	CbGpPWpGaD
Irinotecan—BCHE—Metabolism—AKR1C3—uterine cancer	6.37e-06	0.000383	CbGpPWpGaD
Irinotecan—ACHE—Metabolism of proteins—CCL2—uterine cancer	6.35e-06	0.000381	CbGpPWpGaD
Irinotecan—ALB—Metabolism—STAR—uterine cancer	6.28e-06	0.000377	CbGpPWpGaD
Irinotecan—ALB—Metabolism—AKR1B1—uterine cancer	6.28e-06	0.000377	CbGpPWpGaD
Irinotecan—SLCO1B1—Metabolism—AKR1C3—uterine cancer	6.21e-06	0.000373	CbGpPWpGaD
Irinotecan—ALB—Metabolism of lipids and lipoproteins—CYP19A1—uterine cancer	6.21e-06	0.000373	CbGpPWpGaD
Irinotecan—ABCG2—Metabolism—CYP11A1—uterine cancer	6.09e-06	0.000366	CbGpPWpGaD
Irinotecan—CYP3A7—Metabolism—CYP11A1—uterine cancer	6.04e-06	0.000362	CbGpPWpGaD
Irinotecan—ACHE—Neuronal System—HRAS—uterine cancer	6.03e-06	0.000362	CbGpPWpGaD
Irinotecan—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1B—uterine cancer	5.92e-06	0.000355	CbGpPWpGaD
Irinotecan—CYP2B6—Metabolism—POLD1—uterine cancer	5.86e-06	0.000352	CbGpPWpGaD
Irinotecan—ABCG2—Metabolism—AKR1C3—uterine cancer	5.75e-06	0.000345	CbGpPWpGaD
Irinotecan—CYP3A5—Metabolism—POLD1—uterine cancer	5.72e-06	0.000344	CbGpPWpGaD
Irinotecan—CYP3A7—Metabolism—AKR1C3—uterine cancer	5.7e-06	0.000342	CbGpPWpGaD
Irinotecan—BCHE—Metabolism of proteins—CCL2—uterine cancer	5.67e-06	0.00034	CbGpPWpGaD
Irinotecan—ABCB1—Integrated Pancreatic Cancer Pathway—CTNNB1—uterine cancer	5.59e-06	0.000336	CbGpPWpGaD
Irinotecan—ACHE—Metabolism—STK11—uterine cancer	5.57e-06	0.000334	CbGpPWpGaD
Irinotecan—ACHE—Metabolism—CYP19A1—uterine cancer	5.57e-06	0.000334	CbGpPWpGaD
Irinotecan—ABCB1—Metabolism—AKR1B1—uterine cancer	5.5e-06	0.00033	CbGpPWpGaD
Irinotecan—ABCB1—Metabolism—STAR—uterine cancer	5.5e-06	0.00033	CbGpPWpGaD
Irinotecan—CYP2B6—Metabolism—AKR1C1—uterine cancer	5.48e-06	0.000329	CbGpPWpGaD
Irinotecan—ABCC1—Disease—CDKN2B—uterine cancer	5.45e-06	0.000327	CbGpPWpGaD
Irinotecan—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—uterine cancer	5.45e-06	0.000327	CbGpPWpGaD
Irinotecan—BCHE—Neuronal System—HRAS—uterine cancer	5.38e-06	0.000323	CbGpPWpGaD
Irinotecan—CYP3A5—Metabolism—AKR1C1—uterine cancer	5.35e-06	0.000321	CbGpPWpGaD
Irinotecan—SLC22A3—Metabolism—MTHFR—uterine cancer	5.31e-06	0.000319	CbGpPWpGaD
Irinotecan—UGT1A1—Metabolism—CYP19A1—uterine cancer	5.28e-06	0.000317	CbGpPWpGaD
Irinotecan—UGT1A1—Metabolism—STK11—uterine cancer	5.28e-06	0.000317	CbGpPWpGaD
Irinotecan—UGT1A9—Metabolism—STK11—uterine cancer	5.28e-06	0.000317	CbGpPWpGaD
Irinotecan—UGT1A9—Metabolism—CYP19A1—uterine cancer	5.28e-06	0.000317	CbGpPWpGaD
Irinotecan—ACHE—Metabolism of lipids and lipoproteins—PTEN—uterine cancer	5.23e-06	0.000314	CbGpPWpGaD
Irinotecan—ABCB1—Integrated Pancreatic Cancer Pathway—EP300—uterine cancer	5.19e-06	0.000312	CbGpPWpGaD
Irinotecan—ABCC1—Metabolism—CYP19A1—uterine cancer	5.09e-06	0.000306	CbGpPWpGaD
Irinotecan—ABCC1—Metabolism—STK11—uterine cancer	5.09e-06	0.000306	CbGpPWpGaD
Irinotecan—ACHE—Metabolism of proteins—CXCL8—uterine cancer	5.02e-06	0.000301	CbGpPWpGaD
Irinotecan—ALB—Platelet activation, signaling and aggregation—VEGFA—uterine cancer	5e-06	0.0003	CbGpPWpGaD
Irinotecan—ACHE—Metabolism of lipids and lipoproteins—EP300—uterine cancer	4.98e-06	0.000299	CbGpPWpGaD
Irinotecan—ABCC1—Disease—SMAD3—uterine cancer	4.98e-06	0.000299	CbGpPWpGaD
Irinotecan—BCHE—Metabolism—STK11—uterine cancer	4.97e-06	0.000298	CbGpPWpGaD
Irinotecan—BCHE—Metabolism—CYP19A1—uterine cancer	4.97e-06	0.000298	CbGpPWpGaD
Irinotecan—UGT1A9—Metabolism of lipids and lipoproteins—PTEN—uterine cancer	4.96e-06	0.000298	CbGpPWpGaD
Irinotecan—ALB—Metabolism—POLD1—uterine cancer	4.93e-06	0.000296	CbGpPWpGaD
Irinotecan—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—uterine cancer	4.92e-06	0.000295	CbGpPWpGaD
Irinotecan—CYP2B6—Metabolism—RRM2—uterine cancer	4.88e-06	0.000293	CbGpPWpGaD
Irinotecan—SLCO1B1—Metabolism—STK11—uterine cancer	4.84e-06	0.000291	CbGpPWpGaD
Irinotecan—SLCO1B1—Metabolism—CYP19A1—uterine cancer	4.84e-06	0.000291	CbGpPWpGaD
Irinotecan—ABCC1—Metabolism of lipids and lipoproteins—PTEN—uterine cancer	4.78e-06	0.000287	CbGpPWpGaD
Irinotecan—CYP3A5—Metabolism—RRM2—uterine cancer	4.77e-06	0.000286	CbGpPWpGaD
Irinotecan—ABCC1—Disease—FGFR2—uterine cancer	4.75e-06	0.000285	CbGpPWpGaD
Irinotecan—CYP2B6—Metabolism—DCN—uterine cancer	4.74e-06	0.000285	CbGpPWpGaD
Irinotecan—UGT1A9—Metabolism of lipids and lipoproteins—EP300—uterine cancer	4.73e-06	0.000284	CbGpPWpGaD
Irinotecan—CYP3A4—Metabolism—SRD5A2—uterine cancer	4.69e-06	0.000282	CbGpPWpGaD
Irinotecan—CYP3A4—Metabolism—NDUFB11—uterine cancer	4.69e-06	0.000282	CbGpPWpGaD
Irinotecan—BCHE—Metabolism of lipids and lipoproteins—PTEN—uterine cancer	4.66e-06	0.00028	CbGpPWpGaD
Irinotecan—CYP3A5—Metabolism—DCN—uterine cancer	4.63e-06	0.000278	CbGpPWpGaD
Irinotecan—ACHE—Metabolism of proteins—CTNNB1—uterine cancer	4.63e-06	0.000278	CbGpPWpGaD
Irinotecan—ALB—Metabolism—AKR1C1—uterine cancer	4.61e-06	0.000277	CbGpPWpGaD
Irinotecan—ABCC1—Disease—MTHFR—uterine cancer	4.57e-06	0.000274	CbGpPWpGaD
Irinotecan—ABCC1—Metabolism of lipids and lipoproteins—EP300—uterine cancer	4.56e-06	0.000274	CbGpPWpGaD
Irinotecan—SLCO1B1—Metabolism of lipids and lipoproteins—PTEN—uterine cancer	4.54e-06	0.000273	CbGpPWpGaD
Irinotecan—ABCG2—Metabolism—CYP19A1—uterine cancer	4.48e-06	0.000269	CbGpPWpGaD
Irinotecan—ABCG2—Metabolism—STK11—uterine cancer	4.48e-06	0.000269	CbGpPWpGaD
Irinotecan—BCHE—Metabolism of proteins—CXCL8—uterine cancer	4.48e-06	0.000269	CbGpPWpGaD
Irinotecan—CYP2B6—Metabolism—CYP11A1—uterine cancer	4.47e-06	0.000268	CbGpPWpGaD
Irinotecan—BCHE—Metabolism of lipids and lipoproteins—EP300—uterine cancer	4.45e-06	0.000267	CbGpPWpGaD
Irinotecan—CYP3A7—Metabolism—CYP19A1—uterine cancer	4.44e-06	0.000267	CbGpPWpGaD
Irinotecan—CYP3A7—Metabolism—STK11—uterine cancer	4.44e-06	0.000267	CbGpPWpGaD
Irinotecan—CYP3A5—Metabolism—CYP11A1—uterine cancer	4.36e-06	0.000262	CbGpPWpGaD
Irinotecan—SLCO1B1—Metabolism of lipids and lipoproteins—EP300—uterine cancer	4.33e-06	0.00026	CbGpPWpGaD
Irinotecan—ABCB1—Metabolism—POLD1—uterine cancer	4.32e-06	0.000259	CbGpPWpGaD
Irinotecan—CYP2B6—Metabolism—AKR1C3—uterine cancer	4.22e-06	0.000253	CbGpPWpGaD
Irinotecan—ACHE—Metabolism—MTHFR—uterine cancer	4.18e-06	0.000251	CbGpPWpGaD
Irinotecan—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—uterine cancer	4.18e-06	0.000251	CbGpPWpGaD
Irinotecan—BCHE—Metabolism of proteins—CTNNB1—uterine cancer	4.13e-06	0.000248	CbGpPWpGaD
Irinotecan—CYP3A5—Metabolism—AKR1C3—uterine cancer	4.12e-06	0.000247	CbGpPWpGaD
Irinotecan—ALB—Metabolism—RRM2—uterine cancer	4.11e-06	0.000247	CbGpPWpGaD
Irinotecan—ABCB1—Metabolism—AKR1C1—uterine cancer	4.04e-06	0.000243	CbGpPWpGaD
Irinotecan—ALB—Metabolism—DCN—uterine cancer	3.99e-06	0.00024	CbGpPWpGaD
Irinotecan—UGT1A1—Metabolism—MTHFR—uterine cancer	3.97e-06	0.000238	CbGpPWpGaD
Irinotecan—UGT1A9—Metabolism—MTHFR—uterine cancer	3.97e-06	0.000238	CbGpPWpGaD
Irinotecan—ALB—Platelet activation, signaling and aggregation—PIK3CA—uterine cancer	3.9e-06	0.000234	CbGpPWpGaD
Irinotecan—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—uterine cancer	3.84e-06	0.000231	CbGpPWpGaD
Irinotecan—ABCC1—Metabolism—MTHFR—uterine cancer	3.83e-06	0.00023	CbGpPWpGaD
Irinotecan—ALB—Metabolism—CYP11A1—uterine cancer	3.76e-06	0.000226	CbGpPWpGaD
Irinotecan—BCHE—Metabolism—MTHFR—uterine cancer	3.73e-06	0.000224	CbGpPWpGaD
Irinotecan—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—uterine cancer	3.72e-06	0.000223	CbGpPWpGaD
Irinotecan—ACHE—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	3.69e-06	0.000221	CbGpPWpGaD
Irinotecan—SLCO1B1—Metabolism—MTHFR—uterine cancer	3.64e-06	0.000218	CbGpPWpGaD
Irinotecan—ABCB1—Metabolism—RRM2—uterine cancer	3.6e-06	0.000216	CbGpPWpGaD
Irinotecan—ALB—Metabolism—AKR1C3—uterine cancer	3.55e-06	0.000213	CbGpPWpGaD
Irinotecan—UGT1A9—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	3.5e-06	0.00021	CbGpPWpGaD
Irinotecan—ABCB1—Metabolism—DCN—uterine cancer	3.5e-06	0.00021	CbGpPWpGaD
Irinotecan—CYP3A4—Metabolism—STAR—uterine cancer	3.39e-06	0.000204	CbGpPWpGaD
Irinotecan—CYP3A4—Metabolism—AKR1B1—uterine cancer	3.39e-06	0.000204	CbGpPWpGaD
Irinotecan—ABCC1—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	3.37e-06	0.000202	CbGpPWpGaD
Irinotecan—ABCG2—Metabolism—MTHFR—uterine cancer	3.37e-06	0.000202	CbGpPWpGaD
Irinotecan—CYP3A7—Metabolism—MTHFR—uterine cancer	3.34e-06	0.0002	CbGpPWpGaD
Irinotecan—ABCB1—Metabolism—CYP11A1—uterine cancer	3.29e-06	0.000198	CbGpPWpGaD
Irinotecan—BCHE—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	3.29e-06	0.000197	CbGpPWpGaD
Irinotecan—CYP2B6—Metabolism—STK11—uterine cancer	3.29e-06	0.000197	CbGpPWpGaD
Irinotecan—CYP2B6—Metabolism—CYP19A1—uterine cancer	3.29e-06	0.000197	CbGpPWpGaD
Irinotecan—CYP3A5—Metabolism—STK11—uterine cancer	3.21e-06	0.000193	CbGpPWpGaD
Irinotecan—CYP3A5—Metabolism—CYP19A1—uterine cancer	3.21e-06	0.000193	CbGpPWpGaD
Irinotecan—SLCO1B1—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	3.21e-06	0.000192	CbGpPWpGaD
Irinotecan—ALB—Platelet activation, signaling and aggregation—AKT1—uterine cancer	3.19e-06	0.000191	CbGpPWpGaD
Irinotecan—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—uterine cancer	3.14e-06	0.000188	CbGpPWpGaD
Irinotecan—ABCB1—Metabolism—AKR1C3—uterine cancer	3.11e-06	0.000187	CbGpPWpGaD
Irinotecan—ABCC1—Disease—ERBB2—uterine cancer	2.98e-06	0.000179	CbGpPWpGaD
Irinotecan—SLC22A3—Metabolism—PTEN—uterine cancer	2.96e-06	0.000177	CbGpPWpGaD
Irinotecan—SLC22A3—Metabolism—EP300—uterine cancer	2.82e-06	0.000169	CbGpPWpGaD
Irinotecan—ALB—Metabolism—STK11—uterine cancer	2.77e-06	0.000166	CbGpPWpGaD
Irinotecan—ALB—Metabolism—CYP19A1—uterine cancer	2.77e-06	0.000166	CbGpPWpGaD
Irinotecan—ABCC1—Disease—CDKN1B—uterine cancer	2.76e-06	0.000166	CbGpPWpGaD
Irinotecan—ALB—Hemostasis—EP300—uterine cancer	2.72e-06	0.000163	CbGpPWpGaD
Irinotecan—CYP3A4—Metabolism—POLD1—uterine cancer	2.66e-06	0.00016	CbGpPWpGaD
Irinotecan—ABCC1—Disease—CTNNB1—uterine cancer	2.61e-06	0.000157	CbGpPWpGaD
Irinotecan—ALB—Metabolism of lipids and lipoproteins—PTEN—uterine cancer	2.6e-06	0.000156	CbGpPWpGaD
Irinotecan—ALB—Hemostasis—VEGFA—uterine cancer	2.58e-06	0.000155	CbGpPWpGaD
Irinotecan—ALB—Hemostasis—NRAS—uterine cancer	2.54e-06	0.000153	CbGpPWpGaD
Irinotecan—ABCC1—Disease—PTEN—uterine cancer	2.54e-06	0.000153	CbGpPWpGaD
Irinotecan—CYP3A4—Metabolism—AKR1C1—uterine cancer	2.49e-06	0.000149	CbGpPWpGaD
Irinotecan—ALB—Metabolism of lipids and lipoproteins—EP300—uterine cancer	2.48e-06	0.000149	CbGpPWpGaD
Irinotecan—CYP2B6—Metabolism—MTHFR—uterine cancer	2.47e-06	0.000148	CbGpPWpGaD
Irinotecan—ABCC1—Disease—EP300—uterine cancer	2.42e-06	0.000146	CbGpPWpGaD
Irinotecan—ABCB1—Metabolism—CYP19A1—uterine cancer	2.42e-06	0.000145	CbGpPWpGaD
Irinotecan—ABCB1—Metabolism—STK11—uterine cancer	2.42e-06	0.000145	CbGpPWpGaD
Irinotecan—CYP3A5—Metabolism—MTHFR—uterine cancer	2.41e-06	0.000145	CbGpPWpGaD
Irinotecan—ACHE—Metabolism—PTEN—uterine cancer	2.33e-06	0.00014	CbGpPWpGaD
Irinotecan—ABCC1—Disease—NRAS—uterine cancer	2.27e-06	0.000136	CbGpPWpGaD
Irinotecan—ACHE—Metabolism—EP300—uterine cancer	2.22e-06	0.000133	CbGpPWpGaD
Irinotecan—CYP3A4—Metabolism—RRM2—uterine cancer	2.22e-06	0.000133	CbGpPWpGaD
Irinotecan—UGT1A1—Metabolism—PTEN—uterine cancer	2.21e-06	0.000133	CbGpPWpGaD
Irinotecan—UGT1A9—Metabolism—PTEN—uterine cancer	2.21e-06	0.000133	CbGpPWpGaD
Irinotecan—ALB—Hemostasis—KRAS—uterine cancer	2.19e-06	0.000131	CbGpPWpGaD
Irinotecan—CYP3A4—Metabolism—DCN—uterine cancer	2.15e-06	0.000129	CbGpPWpGaD
Irinotecan—ABCC1—Metabolism—PTEN—uterine cancer	2.13e-06	0.000128	CbGpPWpGaD
Irinotecan—UGT1A1—Metabolism—EP300—uterine cancer	2.11e-06	0.000126	CbGpPWpGaD
Irinotecan—UGT1A9—Metabolism—EP300—uterine cancer	2.11e-06	0.000126	CbGpPWpGaD
Irinotecan—SLC22A3—Metabolism—PIK3CA—uterine cancer	2.09e-06	0.000125	CbGpPWpGaD
Irinotecan—ALB—Metabolism—MTHFR—uterine cancer	2.08e-06	0.000125	CbGpPWpGaD
Irinotecan—BCHE—Metabolism—PTEN—uterine cancer	2.08e-06	0.000125	CbGpPWpGaD
Irinotecan—ABCC1—Metabolism—EP300—uterine cancer	2.03e-06	0.000122	CbGpPWpGaD
Irinotecan—CYP3A4—Metabolism—CYP11A1—uterine cancer	2.03e-06	0.000122	CbGpPWpGaD
Irinotecan—SLCO1B1—Metabolism—PTEN—uterine cancer	2.02e-06	0.000121	CbGpPWpGaD
Irinotecan—ALB—Hemostasis—PIK3CA—uterine cancer	2.01e-06	0.000121	CbGpPWpGaD
Irinotecan—BCHE—Metabolism—EP300—uterine cancer	1.98e-06	0.000119	CbGpPWpGaD
Irinotecan—ABCC1—Disease—KRAS—uterine cancer	1.95e-06	0.000117	CbGpPWpGaD
Irinotecan—ALB—Hemostasis—TP53—uterine cancer	1.95e-06	0.000117	CbGpPWpGaD
Irinotecan—SLCO1B1—Metabolism—EP300—uterine cancer	1.93e-06	0.000116	CbGpPWpGaD
Irinotecan—CYP3A4—Metabolism—AKR1C3—uterine cancer	1.92e-06	0.000115	CbGpPWpGaD
Irinotecan—ABCG2—Metabolism—PTEN—uterine cancer	1.87e-06	0.000112	CbGpPWpGaD
Irinotecan—ALB—Hemostasis—HRAS—uterine cancer	1.86e-06	0.000112	CbGpPWpGaD
Irinotecan—CYP3A7—Metabolism—PTEN—uterine cancer	1.86e-06	0.000111	CbGpPWpGaD
Irinotecan—ALB—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	1.83e-06	0.00011	CbGpPWpGaD
Irinotecan—ABCB1—Metabolism—MTHFR—uterine cancer	1.82e-06	0.000109	CbGpPWpGaD
Irinotecan—ABCC1—Disease—PIK3CA—uterine cancer	1.79e-06	0.000108	CbGpPWpGaD
Irinotecan—ABCG2—Metabolism—EP300—uterine cancer	1.79e-06	0.000107	CbGpPWpGaD
Irinotecan—CYP3A7—Metabolism—EP300—uterine cancer	1.77e-06	0.000106	CbGpPWpGaD
Irinotecan—SLC22A3—Metabolism—AKT1—uterine cancer	1.7e-06	0.000102	CbGpPWpGaD
Irinotecan—ABCC1—Disease—HRAS—uterine cancer	1.66e-06	9.96e-05	CbGpPWpGaD
Irinotecan—ALB—Hemostasis—AKT1—uterine cancer	1.64e-06	9.87e-05	CbGpPWpGaD
Irinotecan—ACHE—Metabolism—PIK3CA—uterine cancer	1.64e-06	9.86e-05	CbGpPWpGaD
Irinotecan—UGT1A1—Metabolism—PIK3CA—uterine cancer	1.56e-06	9.35e-05	CbGpPWpGaD
Irinotecan—UGT1A9—Metabolism—PIK3CA—uterine cancer	1.56e-06	9.35e-05	CbGpPWpGaD
Irinotecan—ABCC1—Metabolism—PIK3CA—uterine cancer	1.5e-06	9.02e-05	CbGpPWpGaD
Irinotecan—CYP3A4—Metabolism—STK11—uterine cancer	1.49e-06	8.96e-05	CbGpPWpGaD
Irinotecan—CYP3A4—Metabolism—CYP19A1—uterine cancer	1.49e-06	8.96e-05	CbGpPWpGaD
Irinotecan—ABCC1—Disease—AKT1—uterine cancer	1.47e-06	8.8e-05	CbGpPWpGaD
Irinotecan—BCHE—Metabolism—PIK3CA—uterine cancer	1.46e-06	8.79e-05	CbGpPWpGaD
Irinotecan—SLCO1B1—Metabolism—PIK3CA—uterine cancer	1.43e-06	8.57e-05	CbGpPWpGaD
Irinotecan—CYP2B6—Metabolism—PTEN—uterine cancer	1.37e-06	8.25e-05	CbGpPWpGaD
Irinotecan—CYP3A5—Metabolism—PTEN—uterine cancer	1.34e-06	8.06e-05	CbGpPWpGaD
Irinotecan—ACHE—Metabolism—AKT1—uterine cancer	1.34e-06	8.05e-05	CbGpPWpGaD
Irinotecan—ABCG2—Metabolism—PIK3CA—uterine cancer	1.32e-06	7.94e-05	CbGpPWpGaD
Irinotecan—CYP3A7—Metabolism—PIK3CA—uterine cancer	1.31e-06	7.87e-05	CbGpPWpGaD
Irinotecan—CYP2B6—Metabolism—EP300—uterine cancer	1.31e-06	7.86e-05	CbGpPWpGaD
Irinotecan—CYP3A5—Metabolism—EP300—uterine cancer	1.28e-06	7.69e-05	CbGpPWpGaD
Irinotecan—UGT1A1—Metabolism—AKT1—uterine cancer	1.27e-06	7.64e-05	CbGpPWpGaD
Irinotecan—UGT1A9—Metabolism—AKT1—uterine cancer	1.27e-06	7.64e-05	CbGpPWpGaD
Irinotecan—ABCC1—Metabolism—AKT1—uterine cancer	1.23e-06	7.37e-05	CbGpPWpGaD
Irinotecan—BCHE—Metabolism—AKT1—uterine cancer	1.2e-06	7.18e-05	CbGpPWpGaD
Irinotecan—SLCO1B1—Metabolism—AKT1—uterine cancer	1.17e-06	7e-05	CbGpPWpGaD
Irinotecan—ALB—Metabolism—PTEN—uterine cancer	1.16e-06	6.94e-05	CbGpPWpGaD
Irinotecan—CYP3A4—Metabolism—MTHFR—uterine cancer	1.12e-06	6.74e-05	CbGpPWpGaD
Irinotecan—ALB—Metabolism—EP300—uterine cancer	1.1e-06	6.62e-05	CbGpPWpGaD
Irinotecan—ABCG2—Metabolism—AKT1—uterine cancer	1.08e-06	6.48e-05	CbGpPWpGaD
Irinotecan—CYP3A7—Metabolism—AKT1—uterine cancer	1.07e-06	6.43e-05	CbGpPWpGaD
Irinotecan—ABCB1—Metabolism—PTEN—uterine cancer	1.01e-06	6.08e-05	CbGpPWpGaD
Irinotecan—CYP2B6—Metabolism—PIK3CA—uterine cancer	9.69e-07	5.82e-05	CbGpPWpGaD
Irinotecan—ABCB1—Metabolism—EP300—uterine cancer	9.66e-07	5.8e-05	CbGpPWpGaD
Irinotecan—CYP3A5—Metabolism—PIK3CA—uterine cancer	9.47e-07	5.69e-05	CbGpPWpGaD
Irinotecan—ALB—Metabolism—PIK3CA—uterine cancer	8.16e-07	4.9e-05	CbGpPWpGaD
Irinotecan—CYP2B6—Metabolism—AKT1—uterine cancer	7.92e-07	4.75e-05	CbGpPWpGaD
Irinotecan—CYP3A5—Metabolism—AKT1—uterine cancer	7.74e-07	4.64e-05	CbGpPWpGaD
Irinotecan—ABCB1—Metabolism—PIK3CA—uterine cancer	7.15e-07	4.29e-05	CbGpPWpGaD
Irinotecan—ALB—Metabolism—AKT1—uterine cancer	6.66e-07	4e-05	CbGpPWpGaD
Irinotecan—CYP3A4—Metabolism—PTEN—uterine cancer	6.24e-07	3.75e-05	CbGpPWpGaD
Irinotecan—CYP3A4—Metabolism—EP300—uterine cancer	5.95e-07	3.57e-05	CbGpPWpGaD
Irinotecan—ABCB1—Metabolism—AKT1—uterine cancer	5.84e-07	3.5e-05	CbGpPWpGaD
Irinotecan—CYP3A4—Metabolism—PIK3CA—uterine cancer	4.4e-07	2.64e-05	CbGpPWpGaD
Irinotecan—CYP3A4—Metabolism—AKT1—uterine cancer	3.6e-07	2.16e-05	CbGpPWpGaD
